216 related articles for article (PubMed ID: 8436560)
1. Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. II. New anthracycline metabolites produced by a blocked mutant strain RPM-5.
Yoshimoto A; Fujii S; Johdo O; Kubo K; Nishida H; Okamoto R; Takeuchi T
J Antibiot (Tokyo); 1993 Jan; 46(1):56-64. PubMed ID: 8436560
[TBL] [Abstract][Full Text] [Related]
2. Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. I. Isolation of antibiotic-blocked mutants and their characterization.
Yoshimoto A; Johdo O; Fujii S; Kubo K; Nishida H; Okamoto R; Takeuchi T
J Antibiot (Tokyo); 1992 Aug; 45(8):1255-67. PubMed ID: 1399846
[TBL] [Abstract][Full Text] [Related]
3. Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. III. New anthracycline metabolites produced by blocked mutants 4L-660 and YDK-18.
Yoshimoto A; Johdo O; Nishida H; Okamoto R; Takeuchi T
J Antibiot (Tokyo); 1993 Nov; 46(11):1758-61. PubMed ID: 8270500
[No Abstract] [Full Text] [Related]
4. Production of new anthracycline antibiotics 1-hydroxy-oxaunomycin and 6-deoxyoxaunomycin by limited biosynthetic conversion using a daunorubicin-negative mutant.
Yoshimoto A; Johdo O; Tone H; Okamoto R; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1992 Oct; 45(10):1609-17. PubMed ID: 1473988
[TBL] [Abstract][Full Text] [Related]
5. A new anthracycline metabolite D788-1 (10-carboxy-13-deoxocarminomycin) in daunorubicin beer.
Fujii S; Kubo K; Johdo O; Yoshimoto A; Ishikura T; Naganawa H; Sawa T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Mar; 39(3):473-5. PubMed ID: 3700249
[No Abstract] [Full Text] [Related]
6. Anthracycline metabolites from Streptomyces violaceus A262. II. New anthracycline epelmycins produced by a blocked mutant strain SU2-730.
Johdo O; Watanabe Y; Ishikura T; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1991 Oct; 44(10):1121-9. PubMed ID: 1955395
[TBL] [Abstract][Full Text] [Related]
7. Anthracycline metabolites from Streptomyces violaceus A262. IV. New anthracycline yellamycins produced by a variant strain SC-7.
Johdo O; Tone H; Okamoto R; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1991 Oct; 44(10):1155-9. PubMed ID: 1955397
[No Abstract] [Full Text] [Related]
8. Intensely potent anthracycline antibiotic oxaunomycin produced by a blocked mutant of the daunorubicin-producing microorganism.
Yoshimoto A; Fujii S; Johdo O; Kubo K; Ishikura T; Naganawa H; Sawa T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Jul; 39(7):902-9. PubMed ID: 3759649
[TBL] [Abstract][Full Text] [Related]
9. Production of new anthracycline antibiotics by microbial 4-O-methylation using a specific daunorubicin-negative mutant.
Johdo O; Tone H; Okamoto R; Yoshimoto A; Takeuchi T
J Antibiot (Tokyo); 1992 Dec; 45(12):1837-47. PubMed ID: 1490874
[TBL] [Abstract][Full Text] [Related]
10. Anthracycline metabolites from Streptomyces violaceus A262. V. New anthracycline alldimycin A: a minor component isolated from obelmycin beer.
Johdo O; Tone H; Okamoto R; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1991 Oct; 44(10):1160-4. PubMed ID: 1955398
[No Abstract] [Full Text] [Related]
11. A new anthracycline antibiotic SN-706.
Kimura K; Koyama T; Nakayama S; Tamura K; Miyata N; Kawanishi G
J Antibiot (Tokyo); 1988 Dec; 41(12):1918-21. PubMed ID: 3209485
[No Abstract] [Full Text] [Related]
12. Anthracycline metabolites from Streptomyces violaceus A262. III. New anthracycline obelmycins produced by a variant strain SE2-2385.
Johdo O; Watanabe Y; Ishikura T; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1991 Oct; 44(10):1130-40. PubMed ID: 1955396
[TBL] [Abstract][Full Text] [Related]
13. Preparation and biological evaluation of 4-O-demethyldaunorubicin (carminomycin I) and of its 13-dihydro derivative.
Cassinelli G; Grein A; Masi P; Suarato A; Bernardi L; Arcamone F; Di Marco A; Casazza AM; Pratesi G; Soranzo C
J Antibiot (Tokyo); 1978 Mar; 31(3):178-84. PubMed ID: 649513
[TBL] [Abstract][Full Text] [Related]
14. Trisarubicinol, new antitumor anthracycline antibiotic.
Yoshimoto A; Matsuzawa Y; Matsushita Y; Oki T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1981 Nov; 34(11):1492-4. PubMed ID: 7319909
[No Abstract] [Full Text] [Related]
15. Anthracycline metabolites from Streptomyces violaceus A262. I. Isolation of antibiotic-blocked mutants from Streptomyces violaceus A262.
Johdo O; Ishikura T; Yoshimoto A; Takeuchi T
J Antibiot (Tokyo); 1991 Oct; 44(10):1110-20. PubMed ID: 1955394
[TBL] [Abstract][Full Text] [Related]
16. A new anthracycline antibiotic, IT-62-B, converts the morphology of ras-transformed cells back to normal: taxonomy, fermentation, isolation, structure elucidation and biological characterization.
Kawauchi T; Sasaki T; Yoshida K; Matsumoto H; Chen RX; Huang MY; Tsuchiya KS; Otani T
J Antibiot (Tokyo); 1997 Apr; 50(4):297-303. PubMed ID: 9186553
[TBL] [Abstract][Full Text] [Related]
17. Baumycin analogs isolated from Actinomadura sp.
Matsuzawa Y; Yoshimoto A; Kouno K; Oki T
J Antibiot (Tokyo); 1981 Jun; 34(6):774-6. PubMed ID: 7053087
[No Abstract] [Full Text] [Related]
18. Demethyl mutactimycins, new anthracycline antibiotics from Nocardia and Streptomyces strains.
Speitling M; Nattewan P; Yazawa K; Mikami Y; Grün-Wollny I; Ritzau M; Laatsch H; Gräfe U
J Antibiot (Tokyo); 1998 Aug; 51(8):693-8. PubMed ID: 9766460
[TBL] [Abstract][Full Text] [Related]
19. 1,4-Anthraquinone: an anticancer drug that blocks nucleoside transport, inhibits macromolecule synthesis, induces DNA fragmentation, and decreases the growth and viability of L1210 leukemic cells in the same nanomolar range as daunorubicin in vitro.
Perchellet EM; Magill MJ; Huang X; Dalke DM; Hua DH; Perchellet JP
Anticancer Drugs; 2000 Jun; 11(5):339-52. PubMed ID: 10912950
[TBL] [Abstract][Full Text] [Related]
20. 13-Deoxycarminomycin, a new biosynthetic anthracycline.
Cassinelli G; Forenza S; Rivola G; Arcamone F; Grein A; Merli S; Casazza AM
J Nat Prod; 1985; 48(3):435-9. PubMed ID: 3861771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
